Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy.
Previous studies by our group have shown that oxidative phosphorylation (OXPHOS) is the main pathway by which pancreatic cancer stem cells (CSCs) meet their energetic requirements; therefore, OXPHOS represents an Achille’s...
Read More